NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Instruments & Supplies · USD

Solventum Corporation (SOLV) Stock Analysis

Solventum Corporation (SOLV) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

SOLV

$91.69

−$0.75 (−0.81%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SOLV with… →

SOLV Key Statistics

As of Sep 4, 2026
Trading
Open
$91.40
Previous Close
$92.44
Day's Range
91.38–92.28
52-Week Range
62.38–94.16
Volume
576.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.69
Valuation
Market Cap
$15.61B
P/E Ratio
11.21
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
12.69
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.22
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.88
EPS (ttm)Profit attributable to each share over the last twelve months.
8.18
Financials (FY)
Revenue (FY)
$8.33B+0.86%
Net Income (FY)
$1.56B+224.84%
Profit marginThe share of revenue left as profit after all costs and taxes.
17.26%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
170.22M
1-Year Return
+26.68%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
1.23M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SOLV Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+15.71%
2025+19.95%
2024 (partial year)−17.43%

As of September 4, 2026.

SOLV Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$8.33B$1.56B18.7%
2024$8.25B$479.00M5.8%
2023$8.20B$1.35B16.4%
2022$8.13B$1.34B16.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$8.33B$4.45B$632.00M$1.56B18.7%
2024$8.25B$4.59B$1.04B$479.00M5.8%
2023$8.20B$4.69B$1.64B$1.35B16.4%
2022$8.13B$4.70B$1.69B$1.34B16.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SOLV Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricSOLVMedical Instruments & Supplies medianvs median
P/E11.2135.610.3x the median
P/S ratio1.883.1741% below
Profit margin17.26%0.85%16.4 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Solventum Corporation (SOLV) carries a market capitalisation of $15.61B. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 20,584 employees.

SOLV last closed at $91.69 on September 4, 2026. That is −$0.75 (−0.81%) against the previous close. Over the past 52 weeks the price has ranged from $62.38 to $94.16. The latest close sits 46.99% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $8.33B. That is +0.86% against the prior fiscal year, when revenue was $8.25B. The same year closed with net income of $1.56B. That is +224.84% against the prior fiscal year. The reported profit margin is 17.26%. That is 16.4 percentage points above the Medical Instruments & Supplies median of 0.85%. Trailing earnings per share are 8.18.

Across the 4 fiscal years on file, revenue moves from $8.13B in 2022 to $8.33B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 11.21 times earnings. That is 0.3 times the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 12.69. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.22. The price-to-sales ratio is 1.88. On price-to-sales that is 40.8% below the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

Beta against the wider market is reported at 0.69. Annualized volatility over the trailing 2 years is 30.35%. Over the trailing twelve months the price has returned +26.68%. The stored price history starts on March 26, 2024, and the total return since then is +14.61%.

Growth & Income

The record shows no dividend for SOLV.

The record holds one complete calendar year, 2025, which returned +19.95%. 2026 is still running; the price is +15.71% year to date.

Peer Comparison

Solventum Corporation (SOLV) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Solventum Corporation SOLV $15.61B 11.2
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Solventum Corporation trades at a P/E of 11.2.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Solventum Corporation

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Visit website →